Last updated: 2026-09-23 13:43:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
BioHarvest Sciences Inc. (BHST) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $1.53, with a market capitalisation of $36.72M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.51 to $12.80. This page covers its latest market performance, valuation, price trends and company information.
$36.72M | |
$1.58 | |
$12.80 | |
$1.51 | |
$1.51 | |
2.95K | |
53.20K | |
-- | |
$12.80 | |
$1.51 | |
-- | |
-- |
BioHarvest Sciences Inc. (BHST) is currently trading at $1.53 as of 2026-09-23 13:37:00, up 1.46% ($0.02) from the previous close of $1.51
During today's regular trading session, BHST has traded between $1.51 and $12.80, with a trading volume of 2.95K shares. The current price is near the lower end of today's range.
Over the past seven days, BioHarvest Sciences Inc. (BHST) moved from $1.80 to $1.53, representing a decline of 14.89% ($0.27).
The stock traded between $1.51 and $1.87 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 30.53 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0.2%
BHST is currently trading at $1.53, placing it 0.2% of the way from its 52-week low of $1.51 to its 52-week high of $12.80. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.
| Employees | 89 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of BioHarvest Sciences Inc. (BHST) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.